Abstract
This study was undertaken to examine the clinical relevance of antibodies detected in the sera of patients following renal transplantation. The sera from 23 transplant recipients with acute rejection and 10 transplant recipients with diagnosed chronic rejection were tested against various epithelial, monocyte and endothelial cell lines (A549, HTB44, primary renal epithelial, U937 and Ea-hy 926). The test used for detecting binding antibodies was a simple, indirect immunofluorescence flow cytometric technique. The level of IgG antibodies directed against the test cell lines was examined in the sera of patients with mild or severe rejection and compared to those of patients showing no signs of rejection. Patients with chronic rejection were found to have increased levels of antibodies (IgG and IgM) when compared to patients with either end-stage renal failure or patients with stable post-transplant renal function. Antibodies detected by the present technique were directed against antigens found on all cell lines tested, and immunoblotting indicated that they were directed against non-HLA antigens. In conclusion, monitoring for the presence of such antibodies may provide a valuable prognostic indicator of graft rejection in renal transplant patients.
Similar content being viewed by others
References
Al-Hussien KA, Shenton BK, Bell A, Talbot D, Clark K, Rigg K, Forsythe J, Proud J, Taylor RMR (1994) Characterization of donor-directed antibody class in the post-transplant period using flow cytometry in renal transplantation. Transpl Int 7: 182–189
Brasile L, Clarke J, Abrams A, Cerilli J (1989) Risk factor in the development of antibodies to vascular endothelial cells. Transplant Proc 21: 716–717
Cerilli J, Brasile L, Galouzis T, De-Francis MB (1981) Clinical significance of anti-monocyte antibody in kidney transplant recipients. Transplantation 32: 495–497
Cerilli J, Brasile L, Galouzis T, Lampert N, Clarke J (1985) The vascular endothelial cell antigens system. Transplantation 39: 286–289
Cerilli J, Clarke J, Doolin T, Cerilli G, Brasile L (1988) The significance of a donor-specific vessel crossmatch in renal transplantation. Transplantation 46: 359–362
Chapman JR, Deierhoi MH, Carter NP, Ting A, Morris PJ (1985) Analysis of flow cytometry and cytotoxicity cross-matches in renal transplantation. Transplant Proc 17: 2480–2481
Cinti P, Bachetoni A, Trovati A, Berloco P, Pretagostini R Poli L, Molajoni E, Cortesini R (1991) Clinical relevance of donor-specific IgG determination by FACS analysis in renal transplantation. Transplant Proc 23: 1297–1299
Claas F, Schreuder I, Persijn G, Rood J van (1993) HLA and ABO matching in clinical renal transplantation. In: Thompson A, Catto G (eds) Immunology of renal transplantation. Edward Arnold, London, pp 177–187
Dejelo CL, William TC (1977) B-cell cross-match in renal transplantation. Lancet II: 241
Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH (1992) Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 339: 1566–1570
Garovoy MR, Rheinschmidt MA, Bigos M, Perkins H, Colombe B, Feduska N, Salavatierra O (1983) Flow cytometry analysis: a high technology cross-match technique facilitating transplantation. Transplant Proc 15: 1939–1944
Harmer AW, Haskard D, Koffman C, Welsh KI (1990) Novel antibodies associated with unexplained loss of renal allografts. Transpl Int 3: 66–69
Johnson AH, Rossen R, Butler WT (1972) Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection. Tissue Antigens 2: 215–226
Kirby JA, Givan AL, Shenton BK, Talbot D, Frosythe JL, Lennard T, Proud G, Taylor RMR (1990) Renal allograft rejection. Possible involvement of antibody-dependent cell-mediated cytotoxicity. Transplantation 50: 225–229
Lazda VA, Pollak R, Mozes MF, Jonasson O (1988) The relationship between flow cytometer crossmatch results and subsequent rejection episodes in cadaver renal allograft recipients. Transplantation 45: 562–565
Martin S, Brenchley PE, Postlethwaite RJ, Johnson RW Dyer PA (1991) Detection of anti-epithelial cell antibodies in association with paediatric renal transplant failure using a novel microcytotoxicity assay. Tissue Antigens 37: 152–155
Mathews J, Altman D Campbell M, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300: 230–235
Mohanakumar T, Waldren JC, Phibbs M, Mendez-Picon G, Kaplan AM, Lee HM (1982) Serological characterization of antibodies eluted from chronically rejected human renal allografts. Transplantation 32: 61–66
Moraes JR, Pettaway C, Stastny P (1989) Prediction of early kidney transplant rejection by a crossmatch with donor skin. Transplantation 48: 951–952
Moraes JR, Moraes ME, Luo Y, Stastny P (1991) Alloantibodies against epidermis and early kidney transplant rejection. Transplantation 51: 370–373
Patel R, Terasaki P (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280: 735–739
Paul LC, Es LA van, Riviere GB de La, Eernisse G, DeGraeff J (1978) Blood group B antigen on renal endothelium as the target for rejection in an ABO-incompatible recipient. Transplantation 26: 268–271
Paul LC, Claas FH, Es LA van, Kalff MW, DeGraeff J (1979) Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. N Engl J Med 300: 1258–1260
Paul LC, Es LA van, Fleuren G (1979) Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejecting renal allografts. Transplantation 27: 175–179
Paul LC, Baldwin W, Es LA van (1985) Vascular endothelial alloantigens in renal transplantation. Transplantation 40: 117–123
Schook LB, Wood N, Mohanakumar T (1987) Identification of human vascular endothelial cell/monocyte antigenic system using monoclonal antibodies. Transplantation 44: 412–416
Talbot D, Givan AL, Shenton BK, Stratton A, Proud G, Taylor RMR (1989) The relevance of a more sensitive crossmatch assay to renal transplantation. Transplantation 47: 552–555
Terasaki P, Mickey MR, Iwaki Y, Cicciaralli J, Cecka M, Cook D, Yuge J (1989) Long-term survival of kidney grafts. Transplant Proc 21: 615
Williams G, Hume D, Hudson R, Morris P, Kano K, Milgrom F (1968) “Hyperacute” renal-homograft rejection in man. N Engl J Med 279: 611–618
Author information
Authors and Affiliations
About this article
Cite this article
Al-Hussein, K.A., Talbot, D., Proud, G. et al. The clinical significance of post-transplantation non-HLA antibodies in renal transplantation. Transpl Int 8, 214–220 (1995). https://doi.org/10.1007/BF00336540
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00336540